Mirvetuximab

Tax included
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
MedChemExpress 
HY-P99225

Data sheet

Size
Multiple sizes
Reactivity
Antifolate
Application
Cancer-programmed cell death
CAS
1453084-36-0